Clinical Trials
13
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Oral Administration of Actitan-F in Paediatric Diarrhoea
- Conditions
- Chronic Diarrhoea of Infants and/or Young Children
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 136
- Registration Number
- NCT05904938
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria "Federico II",, Napoli, Italia, Italy
🇮🇹ASST Papa Giovanni XXIII, Bergamo, Italy
🇮🇹Azienda Ospedaliera Cannizzaro, UOC Pediatria e PS Pediatrico, Catania, Italy
Administration of a Natural Molecular Complex in Functional Chronic Constipation
- Conditions
- Chronic Constipation
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 86
- Registration Number
- NCT05192317
- Locations
- 🇮🇹
Campus Biomedico, Roma, Lazio, Italy
🇮🇹IRCCS Istituto Clinico Humanitas, Milano, Lombardia, Italy
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
- Conditions
- Irritable Bowel Syndrome
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 71
- Registration Number
- NCT05016024
- Locations
- 🇩🇪
Klinische Forschung Karlsruhe GmbH, Karlsruhe, Germany
🇮🇹Istituto Clinico Humanitas, Rozzano, Milano, Italy
🇮🇹Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy
Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea
- Conditions
- DiarrheaChronic DiarrheaAcute DiarrheaDiarrhea, Infantile
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 240
- Registration Number
- NCT03598010
Efficacy of MEMORMAX in Subjects With MCI
- Conditions
- Mild Cognitive Impairment
- First Posted Date
- 2018-07-10
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 50
- Registration Number
- NCT03581929
- Locations
- 🇮🇹
S.C. di Geriatria Ospedale S. Maria della Misericordia, Perugia, Italy
- Prev
- 1
- 2
- 3
- Next